Issue |
Title |
File |
Vol 95, No 3 (2023) |
Efficacy and safety of patients immunization with chronic obstructive pulmonary disease with monoclonal antibodies |
 (Rus)
|
Antonov V.N., Ignatova G.L.
|
Vol 95, No 3 (2023) |
Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis |
 (Rus)
|
Zaitsev A.A., Leshchenko I.V., Esaulova N.A., Viktorova I.A.
|
Vol 95, No 3 (2023) |
Possibilities of non-invasive diagnosis of fibrotic phenotype of interstitial lung diseases |
 (Rus)
|
Shchepikhin E.I., Shmelev E.I., Ergeshov A.E., Zaytseva A.S., Shergina E.A., Adamovskaya E. .
|
Vol 95, No 3 (2023) |
Interstitial pneumonia with autoimmune features: monocentric prospective study |
 (Rus)
|
Akulkina L.A., Shchepalina A.A., Moiseev A.S., Brovko M.Y., Sholomova V.I., Moiseev S.V.
|
Vol 95, No 3 (2023) |
Clinic and functional features of chronic obstructive pulmonary disease after virus-induced acute exacerbations. |
 (Rus)
|
Shpagina L.A., Kotova O.S., Shpagin I.S., Karmanovskaya S.A., Loktin E.M., Rukavitsyna A.A., Kuznetsova G.V., Gerasimenko D.A., Anikina E.V.
|
Vol 95, No 3 (2023) |
Assessment of inhalation technique in patients with bronchial asthma and chronic obstructive pulmonary disease |
 (Rus)
|
Trushenko N.V., Stoliarevich A.A., Andriukov B.G., Nuralieva G.S., Tsareva N.A., Lavginova B.B., Avdeev S.N.
|
Vol 95, No 2 (2023) |
Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases |
 (Rus)
|
Sbikina E.S., Vinnitskaya E.V., Batskikh S.N., Sandler Y.G., Saliev K.G., Khaimenova T.Y., Bordin D.S.
|
Vol 95, No 2 (2023) |
Irritable bowel syndrome phenotypes: leading factors of genetics and epigenetics, mechanisms of formation |
 (Rus)
|
Gaus O.V., Livzan M.A.
|
Vol 95, No 2 (2023) |
Liver damage in children and adolescents with newly diagnosed celiac disease: clinical and anamnestic, serological and morphological patterns |
 (Rus)
|
Cherkasova E.A., Klimov L.Y., Kuryaninova V.A., Yagupova A.V., Ivenskaya T.A., Gliva A.V.
|
Vol 95, No 2 (2023) |
Features of the upper gastrointestinal tract mucous membrane state in patients with atherosclerosis of the mesenteric arteries |
 (Rus)
|
Selyanina A.A., Dolgushina A.I., Kusnezowa A.S., Genkel V.V., Olevskaya E.R., Nikushkina K.V., Khikhlova A.O.
|
Vol 95, No 2 (2023) |
The course and clinical manifestations of Peutz–Jeghers syndrome in the Russian population |
 (Rus)
|
Savelyeva Т.A., Ponomarenko А.A., Shelygin Y.A., Kuzminov А.M., Vyshegorodtsev D.V., Loginova А.N., Pikunov D.Y., Goncharova Е.P., Likutov А.A., Mainovskaya О.A., Tsukanov А.S.
|
Vol 95, No 2 (2023) |
The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion |
 (Rus)
|
Baulo E.V., Belostotsky N.I., Akhmadullina O.V., Dbar S.R., Bykova S.V., Parfenov A.I.
|
Vol 95, No 2 (2023) |
Comparative analysis of the intestinal microbiota in patients with exocrine pancreatic insufficiency of various severity |
 (Rus)
|
Maev I.V., Levchenko A.I., Galeeva J.S., Andreev D.N., Osipenko J.V., Bordin D.S., Ilyina E.N.
|
Vol 95, No 2 (2023) |
Effectiveness of empirical Helicobacter pylori eradication therapy with furazolidone in Russia: results from the European Registry on Helicobacter pylori Management (Hp-EuReg) |
 (Rus)
|
Bordin D.S., Voynovan I.N., Sarsenbaeva A.S., Zaytsev O.V., Abdulkhakov R.A., Bakulina N.V., Bakulin I.G., Osipenko M.F., Livzan M.A., Alekseenko S.A., Tarasova L.V., Tarasova G.N., Bogomolov P.O., Maev I.V., Andreev D.N., Abdulkhakov S.R., Starostin B.D., Bakanova N.V., Kononova A.G., Kolbasnikov S.V., Bueverova E.L., Moreira L., Megraud F., O'Morain C., Perez Nyssen O., Gisbert J.
|
Vol 95, No 1 (2023) |
Pre-exposure prophylaxis of new COVID-19 coronavirus infection with tixagevimab/cilgavimab in adult Moscow patients with primary immunodeficiencies |
 (Rus)
|
Roppelt A.A., Lebedkina M.S., Chernov A.A., Kruglova T.S., Mukhina O.A., Yukhnovskaya Y.D., Samedova F.A., Mаrkina U.A., Andrenova G.V., Karaulov A.V., Lysenko M.A., Fomina D.S.
|
Vol 95, No 1 (2023) |
Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19 |
 (Rus)
|
Zhuravleva M.V., Chulanov V.P., Gagarina J.V., Shabalina E.A.
|
Vol 95, No 1 (2023) |
Risk factors for adverse outcomes in elderly patients with asthma and severe COVID-19 at the hospital and early post-hospital stages |
 (Rus)
|
Avdeev S.N., Gaynitdinova V.V., Pozdniakova A.A., Vlasenko A.E., Gneusheva T.I., Baytemerova I.V.
|
Vol 95, No 1 (2023) |
New opportunities for complex treatment of oropharyngeal candidiasis in HIV-infected patients in the later stages of the disease |
 (Rus)
|
Charushin A.O., Elovikov A.M., Charushina I.P.
|
Vol 95, No 1 (2023) |
Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study |
 (Rus)
|
Maev I.V., Okhlobystina O.Z., Khalif I.L., Andreev D.N.
|
Vol 95, No 1 (2023) |
Clinical and diagnostic value of including PCR blood test in the traditional algorithm for identifying causative agents of infective endocarditis: a cohort study of 124 patients |
 (Rus)
|
Kotova E.O., Domonova E.A., Kobalava Z.D., Moiseeva A.Y., Pisaryuk A.S., Silveystrova O.Y., Karaulova J.L., Akimkin V.G.
|
Vol 95, No 1 (2023) |
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis |
 (Rus)
|
Kotenko O.N., Abolyan L.V., Kuteinikov V.I., Vinogradov V.E., Fomin V.V.
|
Vol 95, No 1 (2023) |
Obstructive sleep apnea syndrome and cardiovascular risk factors in the antihypertensive therapy “escape” phenomenon |
 (Rus)
|
Mikhailova O.O., Elfimova E.M., Litvin A.Y., Chazova I.E.
|
Vol 95, No 1 (2023) |
Comorbid status of patients with hypertension |
 (Rus)
|
Osmanov E.M., Reshetnikov V.A., Manyakov R.R., Garaeva A.S., Korkmazova L.K., Demenkova V.V.
|
Vol 94, No 12 (2022) |
Treatment of toxic hepatitis in COVID-19 patients |
 (Rus)
|
Maev I.V., Shaburov R.I., Pavlov A.I., Molodova A.I., Karakozov A.G., Kazakov S.P., Lebedeva E.G., Ivolgin A.F., Eremin M.N., Levchenko O.B.
|
Vol 94, No 12 (2022) |
Efficacy of esophagus protection in complex treatment of erosive gastroesophageal reflux disease: a systematic review and meta-analysis of controlled trials |
 (Rus)
|
Bordin D.S., Andreev D.N., Maev I.V.
|
Vol 94, No 12 (2022) |
Efficacy and safety of the use of alirocumab in real clinical practice |
 (Rus)
|
Korneva V.A., Kuznetsova T.Y., Scopets I.S., Vezikova N.N.
|
Vol 94, No 12 (2022) |
Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties |
 (Rus)
|
Sinopalnikov A.I., Rachina S.A., Vasilyeva I.S., Pigusova N.A., Karpova O.Y.
|
Vol 94, No 12 (2022) |
Dynamics of NT-proBNP and ST2 levels as markers of heart failure in patients with endogenous Cushing syndrome (hypercortisolism) |
 (Rus)
|
Kosharnaia R.S., Belaya Z.E., Zuraeva Z.T., Michurova M.S., Kalashnikov V.Y.
|
Vol 94, No 12 (2022) |
Pharmacoepidemiological analysis of antihypertensive therapy in older age groups with senile asthenia syndrome |
 (Rus)
|
Davidov E.L., Yaskevich R.A.
|
Vol 94, No 12 (2022) |
Resumption of anticoagulant therapy after major bleeding and the risk of negative events in patients with atrial fibrillation (based on REGistry of Long-term AnTithrombotic TherApy-2 – REGATA) |
 (Rus)
|
Kropacheva E.S., Zemlyanskaya O.A., Krivosheeva E.N., Panchenko E.P.
|
Vol 94, No 12 (2022) |
Subclinical markers of liver damage in patients with arterial hypertension and obesity |
 (Rus)
|
Sadulaeva I.A., Yushchuk E.N., Khalikova L.F., Krikunova O.V., Trofimenko O.S., Medvedeva E.G.
|
Vol 94, No 12 (2022) |
Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions |
 (Rus)
|
Toktogulova N.A., Sultanalieva R.B., Tuhvatshin R.R., Kaliev T.K.
|
Vol 94, No 12 (2022) |
Vasoprotective effect of effective lipid-lowering therapy in patients with ST-segment elevation myocardial infarction |
 (Rus)
|
Salyamova L.I., Khromova A.A., Kvasova O.G., Avdeeva I.V., Borisova N.A., Korenkova K.N., Polezhaeva K.N., Oleynikov V.E.
|
Vol 94, No 11 (2022) |
The informative value of CD3+CD4+ and CD3+CD8+ T-cell count and cHIS scale as predictors of severe COVID-19 when using interleukin-6 receptor blockers in the in-hospital setting |
 (Rus)
|
Kruglova T.S., Fomina D.S.
|
Vol 94, No 11 (2022) |
Prospects and possibilities for the treatment of patients with long COVID-19 syndrome |
 (Rus)
|
Tanashyan M.M., Raskurazhev A.A., Kuznetsova P.I., Bely P.A., Zaslavskaya K.I.
|
Vol 94, No 11 (2022) |
A new approach to etiotropic therapy ARVI in children |
 (Rus)
|
Sabitov A.U., Kovtun O.P., Esaulenko E.V., Sorokin P.V.
|
Vol 94, No 11 (2022) |
Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial |
 (Rus)
|
Avdeeva M.G., Belousova O.N., Orlova E.A., Khamitov R.F., Shvarts Y.G., Kravchenko I.E.
|
Vol 94, No 11 (2022) |
The mechanisms of anti-inflammatory action of enisamium iodide |
 (Rus)
|
Kareva E.N., Fedotcheva T.A., Semeikin A.V., Kochina N.A., Krasnoshchok E.V., Shimanovskii N.L.
|
Vol 94, No 11 (2022) |
Impact of vaccination with pneumococcal vaccines on recurrent pneumonia in patients with chronic obstructive pulmonary disease |
 (Rus)
|
Ignatova G.L., Antonov V.N.
|
Vol 94, No 11 (2022) |
Analysis of fatal outcomes of meningococcal infection in adults |
 (Rus)
|
Zhdanov K.V., Kovalenko A.N., Chirsky V.S., Gusev D.A., Nalivkina N.A., Zinserling V.A., Grigoriev S.G., Khairutdinova R.A., Isakov A.N., Sharabkhanov V.V.
|
Vol 94, No 11 (2022) |
Predictors of severe course of new coronavirus infection (COVID-19): study design |
 (Rus)
|
Mishchenko T.A., Ermakova P.A., Ermakova A.A., Tseller L.P., Rogozhkina Y.A., Verteletskaya M.I., Burakevich O.A., Kardashina Z.Z.
|
Vol 94, No 11 (2022) |
Dynamics of the structure of renal tuberculosis over 20 years |
 (Rus)
|
Kulchavenya E.V., Kholtobin D.P.
|
Vol 94, No 11 (2022) |
Regional Vascular Center in a COVID-19 pandemic: what changed in 2020 compared to 2019 in patients with ST Elevation Myocardial Infarction? |
 (Rus)
|
Syrkina A.G., Ryabov V.V.
|
Vol 94, No 10 (2022) |
Prospects of using the nucleoside analogue riamilovir in patients with SARS-CoV-2 infection |
 (Rus)
|
Maltsev O.V., Kasyanenko K.V., Kozlov K.V., Zhdanov K.V., Lapikov I.I.
|
Vol 94, No 10 (2022) |
Efficacy of Saccharomyces boulardii CNCM I-745 probiotic drug in the prevention and treatment of diarrhea in hospitalized patients with new coronavirus infection COVID-19 |
 (Rus)
|
Maev I.V., Andreev D.N., Sokolov P.S., Fomenko A.К., Devkota M.K., Andreev N.G., Zaborovsky A.V.
|
Vol 94, No 10 (2022) |
Body composition in sarcopenia in middle-aged individuals |
 (Rus)
|
Samoilova I.G., Matveeva M.V., Khoroshunova E.A., Kudlay D.A., Tolmachev I.V., Spirina L.V., Mosienko I.V., Yun V.E., Trifonova E.I., Zakharchuk P.I., Vachadze T.D., Shuliko L.M., Galiukova D.E., Mutalimi V.E.
|
Vol 94, No 10 (2022) |
Adipokines and the cardiorespiratory system in young patients with type 1 diabetes mellitus |
 (Rus)
|
Vengrzhinovskaya O.I., Bondarenko I.Z., Shatskaya O.A., Nikankina l.V., Kalashnikov V.Y., Shestakova M.V., Mokrysheva N.G.
|
Vol 94, No 10 (2022) |
Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy |
 (Rus)
|
Petunina N.A., Telnova M.E., Goncharova E.V., Martirosian N.S., Kuzina I.A.
|
Vol 94, No 10 (2022) |
The role of systemic immune activation in the development of thyroid dysfunction in COVID-19 |
 (Rus)
|
Kolpakova E.A., Elfimova A.R., Nikankina L.V., Troshina E.A.
|
Vol 94, No 9 (2022) |
Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III–IV Criteria |
 (Rus)
|
Andreev D.N., Bordin D.S., Vyuchnova E.S., Lebedeva E.G., Dicheva D.T., Umyarova R.M., Maev I.V.
|
201 - 250 of 548 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 > >>
|